BOTOX Approval in China Redefines Jawline Aesthetics

Aesthetic Medicine Minute

This episode discusses the recent approval of BOTOX® Cosmetic by Allergan Aesthetics in China for treating masseter muscle prominence (MMP), marking it as the first neurotoxin approved for this use in the country. Professor Sun Jiaming from Union Hospital shares insights into the rising demand for minimally invasive facial contouring among Asians. Clinical trials reveal a significant reduction in facial width and improvements in social interaction, attractiveness, and confidence for those receiving the treatment. Learn about the potential global impact and what this development means for individuals seeking a more refined jawline.

Stay connected with Dr. Teri Fisher and keep up with the latest in aesthetic medicine:

• Visit Dr. Fisher's website for more "sculpted confidence": DrTeriFisher.com
• Follow Dr. Fisher on Instagram for more inspiration: @DrTeriFisher
• Listen to Dr. Fisher's long-form podcast: Anti-Aging Insights
• Book an appointment with Dr. Fisher: antiagingvancouver.com

👉 Don't forget to subscribe to "Aesthetic Medicine Minute" for your daily quick sip of aesthetic medicine science, and share with friends who might enjoy it too!

#AestheticMedicineMinute #DrTeriFisher